Table 3. Total mean annual cost per patient (Brazilian Reais 2016).
Annual costs per patient (R$ 2016) | |||
---|---|---|---|
Mean (SD) | Median [95% CI] | % of total societal costs | |
Total costs, societal perspective | 33.872 (34.807) | 25.638 [0–126.789] | |
Direct costs, societal perspective | 27.355 (30.786) | 22.786 [0–114.888] | 80.8% |
Direct costs, payer perspective* | 16.793 (21.713) | 19.915 [0–42.686] | 49.6% |
Inpatient care | 839 (3.148) | 0 [0–9.209] | 2.5% |
Healthcare consultations | 197 (495) | 80 [0–1.304] | 0.6% |
Test and investigations | 870 (1.025) | 49 [0–2.664] | 2.6% |
Prescription medicines | 1.216 (5.788) | 0 [0–6.976] | 3.6% |
Disease-modifying treatments | 13.634 (20.340) | 19.820 [0–28.423] | 40.3% |
Investments, equipment and aids | 25 (279) | 0 [0–80] | 0.08% |
Assistance | 12 (150) | 0 [0–0] | 0.04% |
Patients’ out-of-pocket costs | 7.018 (18.213) | 913 [0–82.034] | 20.7% |
Informal care | 3.544 (8.306) | 0 [0–30.407] | 10.5% |
Indirect costs | 6.517 (12.204) | 0 [0–30.407] | 19.2% |
Short-term absence | 418 (1.551) | 0 [0–7.602] | 1.2% |
Long-term sick-leave 0–12 months | 841 (4.253) | 0 [0–22.805] | 2.5% |
Permanent sick-leave/invalidity pension | 5.258 (11.507) | 0 [0–30.407] | 15.5% |
*excluding patients’ out-of-pocket costs and informal care